Integrated Filing- Financial

Torrent Pharmaceuticals Limited has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. The company confirmed that there are no defaults on loans or debt securities as of the reporting date, reflecting a stable financial position.

The auditor's report provides assurance that the standalone financial results comply with accounting standards and give a fair view of the company’s financial performance.

This solid performance may lead to a positive outlook among investors, indicating operational resilience and financial health.